Inventor · disambiguated record
Agneta Svedberg
Also filed as: SVEDBERG AGNETA
9 granted patents·1 pending application·65 citations·filing 1995–2025
88Inventor score
Top patents by PatentIndex Score
10 records- 0194US9796783B2Anti human interleukin-1 receptor accessory protein (IL1 RAP) antibodies and uses thereofCANTARGIA AB·Filed 2016·Granted Oct 24, 2017·22 cites·14 claims
- 0292US10752692B2Anti human interleukin-1 receptor accessory protein (IL1 RAP) antibodies and uses thereofCANTARGIA AB·Filed 2019·Granted Aug 25, 2020·4 cites·17 claims
- 0391US11236172B2Methods of producing an IL-1 RAP antibodiesCANTARGIA AB·Filed 2020·Granted Feb 1, 2022·2 cites·20 claims
- 0491US10562971B2Method of detection of IL1RAP on cells expressing the proteinCANTARGIA AB·Filed 2018·Granted Feb 18, 2020·11 cites·17 claims
- 0589US10100119B2Anti-human interleukin-1 receptor accessory protein antibody and its use for treating cancerCANTARGIA AB·Filed 2015·Granted Oct 16, 2018·10 cites·18 claims
- 0688US10287357B2Methods of treating cancer using anti human interleukin-1 receptor accessory protein (IL1 RAP) antibodiesCANTARGIA AB·Filed 2017·Granted May 14, 2019·6 cites·15 claims
- 0788US2025340657A1Methods of Treating IL1RAP Associated Cancers with Anti Human Interleukin-1 Receptor Accessory Protein (IL1 RAP) AntibodiesCANTARGIA AB·Filed 2025·Application pending·0 cites
- 0878US12398213B2Methods of treating IL1RAP associated cancers with anti human interleukin-1 receptor accessory protein (IL1 RAP) antibodiesCANTARGIA AB·Filed 2021·Granted Aug 26, 2025·0 cites·19 claims
- 0955US5728713AUse of quinoline-3-carboxamide compoundsPHARMACIA & UPJOHN·Filed 1995·Granted Mar 17, 1998·6 cites·6 claims
- 1032US5726183AUse of quinoline-3-carboxamide compoundsPHARMCIA & UPJOHN·Filed 1995·Granted Mar 10, 1998·4 cites·6 claims
Join the waitlist — get patent alerts
Get an alert when Agneta Svedberg files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →